Darrel P. Cohen - Aug 16, 2023 Form 4 Insider Report for Viracta Therapeutics, Inc. (VIRX)

Signature
/s/ Daniel Chevallard, as Attorny-in-Fact
Stock symbol
VIRX
Transactions as of
Aug 16, 2023
Transactions value $
$0
Form type
4
Date filed
8/18/2023, 04:46 PM
Previous filing
Aug 16, 2023
Next filing
Mar 13, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIRX Stock Option (Right to Buy) Award $0 +235K $0.00 235K Aug 16, 2023 Common Stock 235K $1.23 Direct F1
transaction VIRX Stock Option (Right to Buy) Award $0 +265K $0.00 265K Aug 16, 2023 Common Stock 265K $1.23 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the total shares subject to the Option will vest on the one (1)-year anniversary of the Vesting Commencement Date (as defined below) and 1/48th of the total shares subject to the Option will vest each month thereafter on the same day of the month as the Vesting Commencement Date, subject to the reporting person continuing to be a Service Provider in accordance with the Company's 2021 Inducement Equity Incentive Plan through each such date. The Vesting Commencement Date is August 7, 2023.
F2 Twenty-five percent (25%) of the total shares subject to the Option will vest on the one (1)-year anniversary of the Vesting Commencement Date (as defined below) and 1/48th of the total shares subject to the Option will vest each month thereafter on the same day of the month as the Vesting Commencement Date, subject to the reporting person continuing to be a Service Provider in accordance with the Company's 2021 Equity Incentive Plan through each such date. The Vesting Commencement Date is August 7, 2023.